The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients

HIV Medicine

Volumn 9, Issue 9, 2008, Pages 771-779

  van den Bout van den Beukel, C J P ^a   van den Bos, M ^a   Oyen, W J G ^a   Hermus, Ad R M M ^a   Sweep, F C G J ^a   Tack, C J J ^a   Bosch, M E W ^a   Burger, D M ^a   Koopmans, P P ^a   van der Ven, André J A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; Cholecalciferol supplementation; HIV AIDS; Insulin sensitivity; Vitamin D deficiency

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CALCITRIOL; CHOLESTEROL; COLECALCIFEROL; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; PARATHYROID HORMONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIET RESTRICTION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BODY FAT DISTRIBUTION; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 54049085390     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00630.x     Document Type: Article

References (35)

1. van den Bout-van den Beukel C, Fievez L, Michels M et al. Vitamin D deficiency among HIV1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Research and Human Retroviruses, in press.
2. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev 2006; 64: 226-233.
3. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
4. Bischoff-Ferrari HA, Dietrich T, Orav EJ, wson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: A population-based study of younger and older adults. Am J Med 2004; 116: 634-639.
5. Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis 2006; 42: 108-114.
6. Thomas J, Doherty SM. HIV infection - a risk factor for osteoporosis. J Acquir Immune Defic Syndr 2003; 33: 281-291.
7. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 2006; 281: 11205-11213.
8. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006; 290: E916-E924.
9. Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
10. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1alpha,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 2001; 15: 2751-2753.
11. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995; 27: 181-188.
12. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
13. Tai K, Need AG, Horowitz M, Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008.
14. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: The Rancho Bernardo Study. Metabolism 2002; 51: 356-359.
15. Hitman GA, Mannan N, McDermott MF et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 1998; 47: 688-690.
16. van Hoof HJ, Swinkels LM, van Stevenhagen JJ, van den BH, Ross HA, Benraad TJ. Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin D. J Chromatogr 1993; 621: 33-39.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. McComsey GA, Kendall MA, Tebas P et al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 2007; 21: 2473-2482.
19. Mondy K, Powderly WG, Claxton SA et al. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J Acquir Immune Defic Syndr 2005; 38: 426-431.
20. Ooms ME, Roos JC, Bezemer PD, van d V, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 1995; 80: 1052-1058.
21. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-759.
22. Haug CJ, Aukrust P, Haug E, Morkrid L, Muller F, Froland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998; 83: 3832-3838.
23. Hawkins GA, Cramer SD, Zheng SL et al. Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk. Prostate 2002; 53: 175-178.
24. Lopez ER, Regulla K, Pani MA, Krause M, Usadel KH, Badenhoop K. CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans. J Steroid Biochem Mol Biol 2004; 89-90: 155-157.
25. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003; 17: 513-520.
26. Qaqish RB, Sims KA. Bone disorders associated with the human immunodeficiency virus: Pathogenesis and management. Pharmacotherapy 2004; 24: 1331-1346.
27. Ramayo E, Gonzalez-Moreno MP, Macias J et al. Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2005; 21: 915-921.
28. Madeddu G, Spanu A, Solinas P et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004; 48: 39-48.
29. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: A meta-analysis. Q J Med 2007; 100: 185-192.
30. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258-261.
31. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 1998; 74: 365-366.
32. Hida Y, Kawada T, Kayahashi S, Ishihara T, Fushiki T. Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells. Life Sci 1998; 62: L205-L211.
33. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004; 10: 355-361.
34. Gavi S, Feiner JJ, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA. Limb fat to trunk fat ratio in elderly persons is a strong determinant of insulin resistance and adiponectin levels. J Gerontol A Biol Sci Med Sci 2007; 62: 997-1001.
35. Wohl DA, McComsey G, Tebas P et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis 2006; 43: 645-653.